Global Burn Care Market is expected to grow at a substantial CAGR of 7.3% in the forecast period of 2019 to 2026. The years considered for study are as mentioned below:

Access Full Report at https://www.databridgemarketresearch.com/reports/global-burn-care-market

Global burn care market is a fragmented market which includes key players and local players. The market is growing owing to the favourable market scenario. The market has a prominent growth in upcoming years due to increasing incidence of burn injuries and rising number of emergency centres and burn units.

The market has witnessed developments in terms of merger and acquisitions or product launches to enhance the product portfolio to meet the rising demand of the market. For instance, In June 2018, KCI Licensing, Inc. acquires Crawford Healthcare to create wound care portfolio. Acelity decided to expand its portfolio by positioning itself globally in advanced wound care methodology. The acquisition helped in the growth of the business to help in the improvement of patient’s care with the best and advanced products in the market. It also helped in the expansion of clinicians and better exposure to revivals globally.

KCI Licensing, Inc. has dominated the global burn care market. The other key players existing in the market includes Smith & Nephew, Mölnlycke Health Care AB, 3M, ConvaTec Group PLC, Accell Group, Anika Therapeutics, Inc., B. Braun Melsungen AG, Cardinal Health, Coloplast Pty Ltd, DeRoyal Industries, Inc., Hollister Incorporated, Integra LifeSciences Corporation, Medline Industries, Inc., PAUL HARTMANN AG, Polymedics Innovations Inc. among others.

KCI Licensing, Inc.

KCI Licensing, Inc. is headquartered in Texas, U.S. The company focuses on providing products in burn care to improve the lives of the patients. The product categories of the company include wound management, open abdomen management, incision management, epidermal harvesting, animal health in which wound management is market focused category.

• In May 2019, CPPIB and PSP agreed to sell Acelity and its KCI Licensing, Inc. subsidiaries to 3M. The combination of 3M with KCI will accelerate the business in customer experience, innovation, economic evidence and much more which would successfully transform KCI Licensing, Inc. to heal patients and to improve clinical outcomes in the industry.

The company has global networks through direct sales representatives and distributors in Europe, Asia Pacific, Middle East and Africa, North America, South America.

Smith & Nephew

Smith & Nephew is headquartered in London, U.K was founded in 1856. The company focuses towards designing, developing and selling medical devices to access the wound and burn management. The company operates through nine business segments which are knee implants, advanced wound care, sports medicine joint repair, hip implants, arthroscopic enabling technologies, trauma & extremities, advanced wound bioactives, advanced wound devices, other surgical businesses. Advanced wound care is market focused segment. The product categories of the company include advanced wound management, orthopaedic reconstruction, robotics-assistance, sports medicine, trauma & extremities, ear, nose and throat, material composition in which advanced wound management is market focused category. The company has more than 16,000 employees.

• In June 2019, Smith & Nephew announced that they have introduced the new single use PICO 14 negative pressure wound therapy system which has the capability of driven duration of up to 14 days that support its usage in large wounds and is used in deep wounds. With this product launch, the company will increase its portfolio.

It has its global networks through direct sales representatives and distributors in Asia-Pacific, Europe, Middle East and Africa, North America and South America. Its subsidiaries are Blue Belt Technologies UK Limited (U.K.), Neotherix Limited (U.S.), Plus Orthopedics (U.K.) Limited (U.K.), Arthrocare Corporation (U.S.), Bioventus LLC (U.S.), Smith & Nephew Pty Limited (Australia), ArthoCare Medical Devices (Beijing) Co. Limited (China).

Mölnlycke Health Care AB

Mölnlycke Health Care AB is headquartered in Gothenburg, Sweden was founded in 1849. The company focuses to supply and strategize medical solutions to improve presentation in healthcare to the home from the hospital. The product categories of the company include Wound Management and Surgical Solutions in which wound management is market focused category. The company has Approx. 7,700 employees.

• In January 2019, Mölnlycke Health Care AB declared acquisition of M&J Airlaid products. With this acquisition, it will be beneficial in reinforcement of the wound care facilities. It will also support in the supply of the airlaid material which is significant in the production of the advanced wound care dressings. This acquisition will improve Mölnlycke’s security of supply of the airlaid material.

It has its global networks through direct sales representatives and distributors in North America, Europe, Asia-Pacific.